1. Home
  2. TVTX vs GABC Comparison

TVTX vs GABC Comparison

Compare TVTX & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • GABC
  • Stock Information
  • Founded
  • TVTX 2008
  • GABC 1910
  • Country
  • TVTX United States
  • GABC United States
  • Employees
  • TVTX N/A
  • GABC N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • GABC Major Banks
  • Sector
  • TVTX Health Care
  • GABC Finance
  • Exchange
  • TVTX Nasdaq
  • GABC Nasdaq
  • Market Cap
  • TVTX 1.4B
  • GABC 1.4B
  • IPO Year
  • TVTX N/A
  • GABC N/A
  • Fundamental
  • Price
  • TVTX $14.23
  • GABC $37.03
  • Analyst Decision
  • TVTX Strong Buy
  • GABC Buy
  • Analyst Count
  • TVTX 15
  • GABC 4
  • Target Price
  • TVTX $33.57
  • GABC $44.50
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • GABC 120.9K
  • Earning Date
  • TVTX 07-31-2025
  • GABC 07-28-2025
  • Dividend Yield
  • TVTX N/A
  • GABC 3.15%
  • EPS Growth
  • TVTX N/A
  • GABC N/A
  • EPS
  • TVTX N/A
  • GABC 2.43
  • Revenue
  • TVTX $273,533,000.00
  • GABC $256,672,000.00
  • Revenue This Year
  • TVTX $73.84
  • GABC $44.97
  • Revenue Next Year
  • TVTX $46.72
  • GABC $5.76
  • P/E Ratio
  • TVTX N/A
  • GABC $15.11
  • Revenue Growth
  • TVTX 75.65
  • GABC 4.68
  • 52 Week Low
  • TVTX $6.80
  • GABC $32.56
  • 52 Week High
  • TVTX $25.29
  • GABC $47.08
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 40.17
  • GABC 39.55
  • Support Level
  • TVTX $13.88
  • GABC $36.55
  • Resistance Level
  • TVTX $15.04
  • GABC $39.20
  • Average True Range (ATR)
  • TVTX 0.67
  • GABC 0.75
  • MACD
  • TVTX 0.04
  • GABC -0.19
  • Stochastic Oscillator
  • TVTX 36.93
  • GABC 15.09

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.

Share on Social Networks: